Molecular Diagnosis of Epstein-Barr Virus-Related DiseasesMargaret L. Gulley(The University of Texas at San Antonio Health Science Center)Journal of Molecular DiagnosticsFebruary 1, 200110.1016/s1525-1578(10)60642-3Cited by 331Open AccessFull TextSaveCiteExport RISWatch citationsAbstractRelated PapersInfusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant RecipientsCliona M. Rooney, Colton A. Smith, Catherine Y. Ng et al.|Blood|1998|1.1kQuantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.Y. M. Dennis Lo, Lisa Chan, Anthony T.�C. Chan et al.|PubMed|1999|397The Role of Epstein-Barr Virus in Lymphoepithelioma-like CarcinomasJulia C. Iezzoni, M. J. Gaffey, Lawrence M. Weiss|American Journal of Clinical Pathology|1995|379Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipientsSA Riddler, MC Breinig, JL McKnight|Blood|1994|371Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.N L Harris, J A Ferry, S. H. Swerdlow|PubMed|1997|353